| 常用名 | (2-氟-4-甲烷磺酰基-苯基)-{6-[4-(3-异丙基-[1,2,4]噁二唑-5-基)-哌啶-1-基]-5-硝基嘧啶-4-基}-胺 | CAS号 | 733750-99-7 |
|---|---|---|---|
| 价格 | $需询单/100g $需询单/1kg $需询单/100kg $需询单/1000kg | 纯度 | 98.0% |
| 备货期 | 需询单 | 库存 | 询单 |
| 产品详情(用途,包装等)
用途: AR231453 is a potent and selective small molecule agonist of GPR119 that enhances glucose-dependent insulin secretion and glucagon-like peptide 1 (GLP-1) release; Antidiabetic agent.IC50 value: Target: GPR119in vitro: The GPR119-specific agonist AR231453 significantly increased cAMP accumulation and insulin release in both HIT-T15 cells and rodent islets. In both cases, loss of GPR119 rendered AR231453 inactive [1]. In GLUTag cells, a well-established model of intestinal L-cell function, the potent GPR119 agonist AR231453 stimulated cAMP accumulation and GLP-1 release [2].in vivo: AR231453 also enhanced glucose-dependent insulin release in vivo and improved oral glucose tolerance in wild-type mice but not in GPR119-deficient mice. Diabetic KK/A(y) mice were also highly responsive to AR231453. Orally active GPR119 agonists may offer significant promise as novel antihyperglycemic agents acting in a glucose-dependent fashion [1]. When administered in mice, AR231453 increased active GLP-1 levels within 2 min after oral glucose delivery and substantially enhanced total glucose-dependent insulinotropic peptide levels. Blockade of GLP-1 receptor signaling with exendin(9-39) reduced the ability of AR231453 to improve glucose tolerance in mice [2]. 物理化学性质: CAS号:733750-99-7 常用中文名:(2-氟-4-甲烷磺酰基-苯基)-{6-[4-(3-异丙基-[1,2,4]噁二唑-5-基)-哌啶-1-基]-5-硝基嘧啶-4-基}-胺 常用英文名:AR 231453 分子式:C21H24FN7O5S 分子量:505.52300 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A 储存条件:2-8℃ |